ABSTRACT. Methods: A cross sectional study was carried out using questionnaires administered to female nurses and doctors

Similar documents
Quality Improvement Measures for Cervical Cytology Screening

Knowledge, Attitude and Practice regarding Cervical Cancer Screening Amongst Women visiting Tertiary Centre in Kathmandu, Nepal

Promoting Cervical Screening Information for Health Professionals. Cervical Cancer

Knowledge and Attitude of Women Towards Pap Smear Test and Human Papilloma Virus Vaccine

Pap Smears Pelvic Examinations Well Woman Examinations. When should you have them performed???

Shrestha P CORRESPONDENCE

RESEARCH COMMUNICATION

Opinion: Cervical cancer a vaccine preventable disease

Exploring of Cervical Cancer s Knowledge among Female Nursing Students Based on Junior and Senior grades information

Study of awareness about early detection of cervical cancer by pap smear screening amongst women of Bhavnagar District

A Cross Sectional Study on Knowledge, Attitude and Practice of Cervical Cancer Screening Among Women in Thiruvanmiyur, Chennai

PAP smear. (Papanicolaou Test)

Awareness of cervical cancer screening among nursing staff in a tertiary institution of rural India

and treating joins with the top of canal). at risk for cervical carcinomas, cervix.

WELL WOMAN CLINIC-SCREENING PROGRAM FOR CERVICAL CARCINOMAS G. J. Vani Padmaja 1

Northern Ireland cervical screening programme. Information for primary care and smear takers

IMPACT OF SOURCE OF INFORMATION AND AWARENESS ON HEALTH SEEKING BEHAVIOUR OF CERVICAL CANCER PATIENTS IN DAR ES SALAAM, TANZANIA.

PREVALENCE, ASSOCIATED RISK FACTORS AND METHODS OF DIAGNOSING CERVICAL CANCER IN TWO HOSPITALS IN YAOUNDE, CAMEROON

RESEARCH ARTICLE. Shashank Shekhar 1, Chanderdeep Sharma 2 *, Sita Thakur 2, Nidhi Raina 2. Abstract. Introduction

I have no financial interests in any product I will discuss today.

Cervical Cancer Research in South Africa

Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines. June 2013

Department of Pathology, Kathmandu Medical College & Teaching Hospital, Sinamangal, Kathmandu, Nepal

Clinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening

Knowledge, Attitudes and Practices Regarding Cervical Cancer and Screening among Haitian Health Care Workers. KAP Survey

Quarterly laboratory and pathology update from Legacy Laboratory Services in collaboration with Cascade Pathology

I have no financial interests in any product I will discuss today.

2

An Update on Cervical Cancer Screening Recommendations and on the DOH BCC Program

2. Studies of Cancer in Humans

International Journal of Health Sciences and Research ISSN:

Objectives. I have no financial interests in any product I will discuss today. Cervical Cancer Screening Guidelines: Updates and Controversies

Objectives. Background. Background. Background. Background 9/26/16. Update on Cervical and HPV Screening Guidelines: To pap or not to pap?

HPV & CERVICAL CANCER POLICY & LEGISLATIVE TOOLKIT, 3 RD EDITION

Clinical Practice Guidelines June 2013

Awareness about cervical cancers among health workers in Shimla district, Himachal Pradesh, India

Pap Smear and Histopathological Study of Cervical Lesions

What is cervical cancer?

I have no financial interests in any product I will discuss today.

News. Laboratory NEW GUIDELINES DEMONSTRATE GREATER ROLE FOR HPV TESTING IN CERVICAL CANCER SCREENING TIMOTHY UPHOFF, PHD, DABMG, MLS (ASCP) CM

Study of Rate of Hysterectomy in Patients with Cervical Cancer Referring to Radiotherapy and Oncology Ward of Ahvaz Golestan Hospital in

Department of Health Standard for the Cervical Cancer Screening Program. Approval Date: 08 May 2018 Effective Date: 13 May 2018

HPV AND CERVICAL CANCER

Physical after effects and clients satisfaction following colposcopy and cervical biopsy in a Nigerian population

What is HPV and why is it so important?

The data from the ATHENA study and others bring this expectation and the appropriateness of the guidelines for women aged into question.

KNOWLEDGE AND PRACTICE OF LADY HEALTH VISITORS REGARDING CERVICAL CANCER IN PUBLIC SECTOR MATERNAL AND CHILD HEALTH CENTERS IN LAHORE, PAKISTAN

Evaluation of Level of Utilization of Cervical Cancer Screening Services in Health Facilities in Nasarawa LGA of Kano State of Nigeria

Human Papillomavirus

Complete Summary GUIDELINE TITLE. Cervical cytology screening. BIBLIOGRAPHIC SOURCE(S)

Cervical cancer screening in vaccinated population

Cervical screening: your results explained. Updated guidance

CERVIX. MLS Basic histological diagnosis MLS HIST 422 Semester 8- batch 7 L12 : Dr. Ali Eltayb.

Focus on Cervical Cancer: Key Messages. Cancer System Quality Index 2016

COLLEGE WOMEN S PERCEPTIONS OF HPV VACCINES AND THEIR PERCEIVED BARRIERS TO ADOPTION OF VACCINATION

HPV testing For women with high-grade abnormal Pap tests. p 1

Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two

Cervical Screening. What Pacific women need to know

STUDY OF EARLY DETECTION OF CERVICAL CANCER BY PAP S SMEAR IN SELECTED SETTING OF PUDUCHERRY

birthplace and length of time in the US:

Making Sense of Cervical Cancer Screening

THE DECLINE IN CERVICAL CANCER incidence

Partha Basu M.D. Screening Group/ Early Detection & Prevention Section

Primary High Risk HPV Testing with Cytology Triage

National Cervical Screening Program MBS Item Descriptors

CEVIRA FINAL RESULTS OF PHASE 2B CLINICAL TRIAL. April 11, 2013

Pap Test. F r e q u e n t l y A s k e d Q u e s t i o n s

Samuel B. Wolf, D.O., F.A.C.O.G. Emerald Coast Obstetrics and Gynecology Panama City Florida

Preventive Care Guideline for Asymptomatic Low Risk Adults Age 18 through 64

Proposed new national cervical screening program. Dr Elizabeth Jackson Obstetrician Gynaecologist Cairns

Knowledge of Carcinoma Cervix among rural women of Reproductive age in Trichy district, India

Dysplasia: layer of the cervical CIN. Intraepithelial Neoplasia. p16 immunostaining. 1, Cervical. Higher-risk, requires CIN.

TISSUE TUMOR MARKER EXPRESSION IN

The Korean Journal of Cytopathology 15 (1) : 17-27, 2004

Clinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening

Prevalence and Determinants of High-risk Human Papillomavirus Infection in Women with High Socioeconomic Status in Seoul, Republic of Korea

Attitudes toward Cervical Cancer and Screening among Married Women Attending Outpatient Clinics at Maternity Hospitals in Baghdad City

Epidemiology of Gynecological Cancers in a Teritiary Care Center (Government General Hospital, Guntur

Summary CHAPTER 1. Introduction

Prevention and Early Detection of Cervix Cancer

Uptake of cervical cancer screening services among female medical practitioners in Ogun State, South-West Nigeria.

Risk factors for precancerous lesions of the cervix in a population of Georgian women

Knowledge of Health Care Providers on HPV Related Issues in Cervical Cancer. F HUSSAIN a, MS FLORA b, K NAHAR c, M KHAN d

Cervical Screening for Dysplasia and Cancer in Patients with HIV

HPV the silent killer, Prevention and diagnosis

Association of Oral Contraceptives and Female Reproductive Tract Carcinomas

Prevent You can prevent cancer of the cervix

FREQUENCY AND RISK FACTORS OF CERVICAL Human papilloma virus INFECTION

CERVICAL CANCER FACTSHEET. What is cervical cancer?

STOP Cancer, before it starts*

Cervical Precancer: Evaluation and Management

October 9, Dear Ms. Chowdhury:

For all women aged Cervical Screening. Frequently Asked Questions. States of Guernsey Public Health Services

Preventing Cervical Cancer 2018 WHAT THIS WILL MEAN FOR PRIMARY CARE

ECC or Margins Positive?

January 15, 2009 (202) PROPOSALS TO IMPROVE CYTOLOGY PROFICIENCY TESTING REQUIRED BY THE CLINICAL LABORATORY IMPROVEMENT AMENDMENTS OF 1988

Pap test results FOR WOMEN WITH AN ABNORMAL PAP TEST

HPV Knowledge Survey Healthcare Providers

Evolving Cervical Cancer Screening Options in Clinical Practice

HUMAN PAPILLOMAVIRUS TESTING

Transcription:

Knowledge, Attitudes and Practice regarding personal cervical cancer screening among Clinical Staff Working in Obstetrics and Gynaecology at Two Tertiary Institutions in Jamaica L Campbell 1 G Reynolds 2, R Stevens 1 ABSTRACT Objectives: The objective of the study was to evaluate knowledge, attitudes and practices with regards to cervical cancer screening among obstetric clinical staff. Methods: A cross sectional study was carried out using questionnaires administered to female nurses and doctors employed to Obstetrics and Gynaecology at the University Hospital of the West Indies, Jamaica as well as the Victoria Jubilee Hospital. The sample comprised of 121 clinical staff members. Extracted data was analyzed using STATA 12 statistical software. Results: The mean age of participants was 34.62 years. 77.8% thought that cervical screening should be done yearly. Only 50.41% considered themselves at risk of developing cervical cancer. 82.64% of participants had previously been screened. The most commonly stated deterrent to screening was a lack of time to attend clinics. Conclusion: While compliance with the practice of cervical screening is comparably favourable to other developing nations there is still need for education among healthcare workers particularly as it relates to risk factors and current international screening recommendations. Implementation of staff screening clinics may prove useful in improving compliance in this busy population. Keywords: Attitudes and practices, cervical cancer, knowledge, Pap, Pap smear From: 1 Department of Obstetrics and Gynecology, Victoria Jubilee Hospital, North Street, Kingston,Jamaica, 2 Faculty of Medical Sciences, University of the West Indies, Mona, Kingston 7, Jamaica. Correspondence: Dr L Campbell, Department of Obstetrics and Gynaecology, The University of the West Indies, Kingston 7, Jamaica, West Indies. E-mail: drleroycampbell@gmail.com INTRODUCTION West Indian Med J DOI: 10.7727/wimj.2016.280

KAP Cervical Cancer Screening in Obstetric Clinical Staff Cervical cancer remains the most common gynaecologic cancer in Jamaica and is second, only to breast cancer, in terms of malignancies afflicting Jamaican women (1). The implementation of organized national screening programs in countries such as the USA and the UK has led to dramatic falls in the cervical cancer rates (2) (3). In Jamaica the programme is not as well organized and screening is primarily caregiver driven. Not surprisingly our statistics remain comparatively poor. The incidence of cervical cancer is more than 4 times greater, in Jamaica than in the United States with the mortality rate locally being almost 6 times greater than rates in the United States (4). Internationally recognized bodies such as the American Congress of Obstetrics and Gynaecology (ACOG), the U.S. Preventive Services Task Force and the American Cancer Society currently recommend that screening with cytology be performed every 3 years commencing at 21 years of age (5). Much of the evidence reflecting knowledge attitudes and personal practices among clinical staff in developing nations has not been very favourable. Darj et al, in a cross sectional investigation of the nursing population in Tanzania made the observation that most nurses (84.6%) had never had a Pap smear examination (6). Similarly another study conducted in Uganda found that 81% of health professionals had never been screened (7). In a Nigerian study only 14.1% of participants reported ever having had a Pap test (8). Only 13% of health care providers in one study conducted in the Democratic People's Republic of Korea (DPRK) had ever had a cervical cytology smear (9). While these figures are quite alarming these findings may not necessarily translate to the Jamaican population. A local investigation was therefore considered necessary to evaluate the 2

Campbell et al knowledge, attitudes and personal practices of our local clinicians as it relates to cervical cancer screening. METHODS A cross sectional study was done. Formal, written consent was obtained from each participant. Questionnaires were administered to female nurses and doctors employed to Obstetrics and Gynaecology at the University Hospital of the West Indies Jamaica as well as the Victoria Jubilee Hospital. Calculation of sample size was done using the Raosoft online calculator (10). The study was approved by the University of the West Indies ethics committee. Data analysis was done using STATA 12 statistical software. RESULTS A total of 121 clinical staff members participated in the study. As expected, from the relative distribution of staff at the institutions, the sample was comprised predominantly of nursing staff accounting for 87% as compared to Doctors (13%). The mean age of participants was 34.62, 95% CI [33.2, 36.04] years with a minimum age of 21(one subject) and a maximum age of 52. The majority (57.85%) of the subjects had children. Among these the distribution was as follows: 3

KAP Cervical Cancer Screening in Obstetric Clinical Staff Table 1. Participants by number of children Number of children Participants(N=63) 1 60.32%, 95% CI [48.24, 72.4] 2 25.4%, 95% CI [14.65, 36.15] 3 12.70%, 95% CI [4.48, 20.92] 4 1.59%, 95% CI [-1.5%, 4.68] Knowledge Table 2: Where does cervical cancer rank among cancers in Jamaican women in terms of frequency (N=118)? Most common 38%, 95% CI [29.24, 46.76] Second most common 51%, 95% CI [41.98, 60.02] Third most common 7.7%, 95% CI [2.89, 12.51] Rare 0.8%, 95% CI [-0.81, 2.41] Don t know 2.5% Table 3: What is the purpose of the pap smear (N=105)? To check for cervical cancer 31%, 95% CI [22.15, 39.85] To check for precancerous lesions of the cervix 68%, 95% CI [59.08, 76.92] To check for inflammation of the cervix 1%, 95% CI [-0.9, 2.9] Table 4: How often should women be screened with a pap smear (N=117)? At least every 5 years starting at age 21 1.7%, 95% CI [-0.64, 4.04] At least once every year starting at age 21 77.8%, 95% CI [70.27, 85.33] At least once every 3 years starting at age 21 18.8%, 95% CI [11.72, 25.88] At least once every year after age 50 1.7%, 95% CI [-0.64, 4.04] 4

Campbell et al The questionnaire listed six of the known risk factors for cervical cancer. Only two respondents were able to identify all six. Table 5 demonstrates the number of risk factors identified and the proportion of respondents. Table 5: Risk factors Number of risk factors identified 1 25 (20.7%) 2 18 (14.9%) 3 28 (23.1%) 4 31 (25.6%) 5 17 (14.0%) 6 2 (1.7%) Number of Participants (percent of total respondents) Attitudes Table 6. Do you think that you are at risk of developing cervical cancer (N=117)? Yes 50.41%, 95% CI [41.35, 59.47] No. 31.40%, 95% CI [22.99, 39.81] Don t know 14.88%, 95% CI [8.43, 21.33] 5

KAP Cervical Cancer Screening in Obstetric Clinical Staff 100% 80% 60% 23 23 Did not have children 40% 20% 38 15 Had children 0% At risk Not at risk Fig. 1. Association between parity and opinion of personal susceptibility. Subjects who considered themselves to be at risk of cervical cancer were more likely to have had children than those who did not consider themselves to be at risk (odds ratio 2.53, 95% CI[1.1031, 5.8180]. Fig 2: Deterrents to regular screening. 6

Campbell et al Practice Table 7. Have you ever had a pap smear (N=121)? Yes 82.64%, 95% CI [75.89, 89.39] No 17.36%, 95% CI [10.61, 24.11] Fig. 3: Previously screened patients. Fig. 4: Interval (in Years) between pap smears. 7

KAP Cervical Cancer Screening in Obstetric Clinical Staff DISCUSSION The majority of respondents in the study correctly identified cervical cancer as a major public health problem. A similar observation was made in a study by Mutyaba et al (7). This was not a surprising observation as cervical cancer patients represent a significant proportion of gynaecological ward admissions. The absence of a formal local screening programme means that it is not uncommon for women to be diagnosed in the advanced stages of cervical cancer when, bleeding or constitutional symptoms prompt presentation for care. Complications such as uraemia from obstructive uropathy, recurrent vaginal haemorrhage and intractable pain from bone metastases can make a significant impression on caregivers. This may explain the observation that although only half of the respondents considered themselves to be at risk of developing cervical cancer over 80% had previously been screened. Human papilloma virus (HPV) is central to the development of cervical cancer and can be detected in 99.7% of cases (11). As a result of this aetiology the epidemiology of cervical cancer closely resembles that of a sexually transmitted disease. Many of the risk factors for cervical cancer are the same as those for sexually transmitted infection, including early age at onset of sexual activity, multiple pregnancies, and multiple sexual partners (12). While not fully understood it has been observed that the relative risk of cervical cancer is increased in current users of oral contraceptives and declines after use ceases (13). In our study all the participants were able to identify at least one risk factor for cervical cancer. Only 2 of the 121 respondents to this question were able to identify all six of the stated risk factors. This suggests that while there is a basic knowledge of the risk factors associated with cervical cancer there is still room for health education on this subject. The Pap test aims to identify abnormal cells sampled from the transformation zone (14). Most subjects in the study correctly identified that the purpose of the pap smear was to check for precancerous lesions of the cervix (Table 3). A third of the participants believed that the pap smear 8

Campbell et al was used to check for cervical cancer, while one participant was under the impression that the purpose of the test was to check for inflammation of the cervix. The diagnosis of invasive cancer is based on histologic assessment of a cervical biopsy specimen. The Pap smear is not an effective tool for the diagnosis of cervical cancer and it is not uncommon for smears to misdiagnose overt malignancy. While inflammatory changes may be a commonly reported abnormality on cytology the purpose of the test is not to diagnose cervical inflammation. While current local practices are widely caregiver driven screening practices have trended towards consistency with internationally accepted recommendations. Screening with cervical smears is recommended three yearly commencing at age 21years regardless of sexual history (7). Previous guidelines recommended yearly screening with screening commencing at 18 years of age or after coitarche; whichever came first(15). Three quarters of the clinical staff sampled thought that cervical cancer screening was to be performed every year commencing at the age of 21 years (Table 4). This finding reflects a lack of up to date knowledge of the current international screening recommendations. Interestingly, however, in spite of the fact that over 75% of participants thought that screening was to be done yearly, only 47.2% of the subjects who had multiple previous pap smears (Figure 3) reported an interval of 1 year between smears (Figure 4). In 2011, a publication from the U.S. Preventive Services Task Force suggested that twice as many colposcopies would be performed if screening were performed annually compared with screening every three years, with only a slightly greater reduction in cancer risk (16). An interval of one year is associated 93.5% reduction compared to 90.8% when an interval of 3 years was used (17). Dissemination of this information is critical in our local, developing, economy; as compliance with newer recommendations would likely yield significant fiscal benefit. Although the vast majority recognized that cervical cancer was an important public health problem in 9

KAP Cervical Cancer Screening in Obstetric Clinical Staff Jamaica, the feeling of personal susceptibility was not, nearly, as universal. Only half of the participants thought that they were at risk of developing cervical cancer (Table 6) a finding similar to those described by Mutyaba et al (7). The reason for this observation is not clear. Perhaps a lack of knowledge of the risk factors for the disease might have led to an erroneous assumption by the participant that she was not at risk. Conversely the participant may have had a good knowledge of the risk factors but did not feel that she displayed any of these factors. One observation in the data is that patients who considered themselves to be at risk of developing cervical cancer were more likely to have had children than participants who thought they were not at risk (Odds ratio 2.5, 95% CI [1.1031 to 5.8180]) (figure 1). One possible explanation is that parous respondents may have been exposed to additional health promotion during antenatal visits. The most frequently stated deterrent to screening was a lack of time (Figure 2). This observation is not surprising as nurses and doctors, by nature of their profession, are very busy people. It is not uncommon for clinical staff in Public hospitals in Jamaica to work very long hours to compensate for staff shortages. Development of hospital based staff oriented clinics may make screening more convenient and thus improve compliance. 80% of respondents had been screened prior. This, though not ideal, compared favourably to the findings of previously published articles (6,7,8,9). CONCLUSION While compliance with the practice of cervical screening is comparably favourable to other developing nations there is still need for education among healthcare workers particularly as it 10

Campbell et al relates to risk factors and current international screening recommendations. Intervention is necessary to secure the welfare of our work force; lest in the course of saving others they neglect themselves. REFERENCES 1. Gibson TN, Hanchard B, Waugh N, McNaughton D. Age-specific incidence of cancer in Kingston and St. Andrew, Jamaica, 2003-2007. West Indian Med J 2010; 59: 456 64. 11

KAP Cervical Cancer Screening in Obstetric Clinical Staff 2. Gustafsson L, Ponten J, Zack M, Adam Ho. International incidence of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control. 1997; 8: 755 63. 3. Cuzick J, Boyle P.Trends in cervical cancer mortality. Cancer Surv 1988; 7: 417 39. 4. Lewis, MJ. A Situational Analysis of Cervical Cancer in Latin America. Washington DC: Panamerican Health Organization. 2004. 5. ACOG. New Cervical Cancer Screening Recommendations from the U.S. Preventive Services Task Force and the American Cancer Society/American Society for Colposcopy and Cervical Pathology/American Society for Clinical Pathology. The American Congress of Obstetricians and Gynecologists. [Online] March 14, 2012. [Cited: August 1, 2012.] Available from: http://www.acog.org. 6. Urasa M, Darj E. Knowledge of cervical cancer and screening practices of nurses at a regional hospital in Tanzania. Afr Health Sci 2011; 11: 48 57. 7. Mutyaba T, Mmiro FA, Weiderpass E. Knowledge, attitudes and practices on cervical cancer screening among the medical workers of Mulago Hospital, Uganda, BMC Med Educ 2006; 6: 13. 8. Gharoro EP, Ikeanyi EN. An appraisal of the level of awareness and utilization of the Pap smear as a cervical cancer screening test among female health workers in a tertiary health institution. Int J Gynecol Cancer. May-Jun 2006; 16: 1063 8. 9. Tran NT, Taylor R, Pyo HS. Knowledge, attitude and practice (KAP) concerning cervical cancer and screening among rural and urban female healthcare practitioners in the Democratic People's Republic of Korea. Asian Pac J Cancer Prev 2011; 12: 3023 8. 12

Campbell et al 10. Raosoft, Inc. Raosoft Sample size calculator. http://www.raosoft.com/. [Online] [Cited: September 23, 2012.] 11. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12. 12. Hoskins, William J, Perez, Carlos A. and Young, Robert, Barakat, Markman, Randall. Principles and Practice of Gynecologic Oncology, 4th Edition. s.l. : Lippincott Williams and Wilkins, 2005. 13. International Collaboration of Epidemiological Studies of Cervical Cancer, Appleby P, Beral V, Berrington de González A, Colin D, Franceschi S, Goodhill A et al. Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet 2007; 10; 370: 1609 21. 14. Feldman S, Sirovich B, Goodman A. Screening for cervical cancer: Rationale and recommendations. UpToDate, Inc. 2012 15. Barakat, Bevers, Gershenson, Hoskins. Handbook of Gynaecologic Oncology. Second Edition. London : Martin Dunitz, 2000. 16. Kulasingam SL, Havrilesky L, Ghebre R, Myers ER. Screening for Cervical Cancer: A decision analysis for the U.S. Preventative Services Task Force. Rockville, MD: Agency for Healthcare Research and Quality, 2011 Report No.: 11-05157-EF-1 17. IARC Working Group on evaluation of cervical cancer screening programmes. Screening for squamous cervical cancer: duration of low risk after negative results of cervical 13

KAP Cervical Cancer Screening in Obstetric Clinical Staff cytology and its implication for screening policies. Br Med J (Clin Res Ed) 1986; 13: 659 64. 14